Merck (MRK) Gains from Investment Securities (2009 - 2026)

Merck (MRK) has 18 years of Gains from Investment Securities data on file, last reported at $66.0 million in Q1 2026.

• Gains from Investment Securities for Q1 2026 came in at $66.0 million, up 160.55% year-over-year; the trailing twelve-month figure through Mar 2026 was $233.0 million (up 5725.0% YoY), and the FY2025 annual result was $58.0 million, down 54.33% from the prior year.
• Gains from Investment Securities retreated to $66.0 million in Q1 2026 per MRK's latest filing, from $172.0 million in the prior quarter.
• Over five years, Gains from Investment Securities peaked at $330.0 million in Q3 2025 and troughed at -$975.0 million in Q3 2022.
• A 5-year average of -$59.6 million and a median of $14.0 million in 2024 frame the typical range for Gains from Investment Securities.
• On a YoY basis, Gains from Investment Securities climbed as much as 243.07% in 2024 and fell as far as 1265.0% in 2024.
• A 5-year view of Gains from Investment Securities shows it stood at -$132.0 million in 2022, then jumped by 115.91% to $21.0 million in 2023, then jumped by 171.43% to $57.0 million in 2024, then soared by 201.75% to $172.0 million in 2025, then tumbled by 61.63% to $66.0 million in 2026.
• Business Quant data shows MRK's Gains from Investment Securities at $66.0 million in Q1 2026, $172.0 million in Q4 2025, and $330.0 million in Q3 2025.